CGNX stock $40.06 pre-market NASDAQ 16 Jan 2026: monitor AI order trends
CGNX stock trades at $40.06 pre-market on NASDAQ in the United States on 16 Jan 2026. Volume is 1,358,420, below the 30‑day average of 1,787,785 shares. Investors are watching machine vision demand and upcoming earnings on 2026-02-12. Cognex Corporation (CGNX) faces a rich valuation with a PE of 62.45 while revenue per share remains $5.79.
Market snapshot pre-market for CGNX stock
Cognex Corporation (CGNX) opened pre-market at $39.56 and sits at $40.06. The intraday range is $39.41–$40.14 and the 52‑week range is $22.67–$49.76.
Market cap stands near $6.80B USD with 167,598,049 shares outstanding. The 50‑day average is $37.63 and the 200‑day average is $36.66, indicating recent outperformance versus long‑term trend.
CGNX stock technicals and momentum
Momentum indicators show a neutral to bullish setup. The RSI is 59.29 and ADX is 25.84, signalling a strong trend. MACD histogram is positive at 0.38 and CCI reads 152.11, suggesting short‑term overbought conditions.
Volatility metrics show ATR $1.09. Bollinger Bands middle sits at $36.79, with upper $38.71. Traders should note the on‑balance volume is negative, while MFI is 64.76, showing decent buying pressure.
CGNX stock financials and valuation
Cognex reported EPS of $0.65 (TTM) and a high trailing PE of 62.45. Revenue per share is $5.79 and free cash flow per share is $1.27. Cash per share is $1.79 and book value per share is $8.88.
Key ratios: price‑to‑sales 6.99, price‑to‑book 4.57, and current ratio 3.96. The company pays an annual dividend of $0.33, a yield near 0.80% USD with a payout ratio around 49%.
Analyst view, ownership and recent CGNX stock news
Analyst coverage shows mixed views. MarketBeat lists an average target near $45.64 and a consensus rating of Hold. Recent filings show Nordea increased its stake by 949,599 shares, boosting institutional interest. Insider selling and targeted downgrades keep sentiment balanced.
Read the institutional buying and broader news at MarketBeat source and the latest CGNX headlines source.
Meyka AI rates CGNX with a score out of 100 and forecast
Meyka AI rates CGNX with a score of 71.53 out of 100 — Grade B+ (BUY). This grade factors S&P 500 and sector comparisons, financial growth, key metrics, analyst consensus, and forecasts.
Meyka AI’s forecast model projects monthly $41.41, quarterly $35.60, and yearly $28.58. Versus the current $40.06, the monthly view implies +3.37% upside, quarterly implies -11.14%, and yearly implies -28.66%. Forecasts are model‑based projections and not guarantees. Meyka AI is an AI‑powered market analysis platform and provides model context only.
Risks and opportunities for CGNX stock
Opportunities include stronger AI and automation demand in manufacturing and logistics. Cognex’s deep‑learning vision software and barcode reader franchises support recurring revenue.
Risks include cyclicality in capital equipment spending, exposure to semiconductor cycles, and a high valuation. Inventory days (166.83) and DSO (64.43) could pressure margins if orders slow.
Final Thoughts
CGNX stock trades at $40.06 USD pre‑market on NASDAQ with mixed signals. Fundamentals show profitable operations, strong margins, and healthy cash, but valuation is rich at a PE of 62.45. Analyst consensus centers near $45.64, while Meyka AI’s model projects monthly $41.41 and yearly $28.58. The monthly forecast suggests a modest +3.37% upside. Investors focused on AI‑driven automation should weigh Cognex’s market position against cyclic risk and a high price multiple. Our view: watch order flows and the 2026‑02‑12 earnings report for visibility. Forecasts are model projections and not guarantees.
FAQs
What is the current price and market status of CGNX stock?
CGNX stock is trading at $40.06 pre‑market on NASDAQ (United States). Volume is 1,358,420 versus an average of 1,787,785 shares, and the 52‑week range is $22.67–$49.76.
When does Cognex report earnings and how could that affect CGNX stock?
Cognex announces earnings on 2026‑02‑12. Results and guidance on automation demand could move CGNX stock strongly, given its high valuation and sensitivity to order trends.
What valuation and metrics should investors watch for CGNX stock?
Key metrics: PE 62.45, price‑to‑sales 6.99, EPS $0.65, free cash flow per share $1.27, and dividend $0.33. Watch margins and order backlog for valuation justification.
What did Meyka AI forecast for CGNX stock and what does it mean?
Meyka AI’s model projects monthly $41.41, quarterly $35.60, and yearly $28.58. These imply short‑term upside but notable annual downside. Forecasts are not guarantees.
Where can I follow CGNX stock news and institutional activity?
Use MarketBeat and company filings for updates. See recent Nordea buying and daily headlines at MarketBeat source and the Nordea filing [source](https://www.marketbeat.com/instant-alerts/filing-nordea-investment-management-ab-purchases-949599-sh
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
